Clinical Trials
15 trialsNCT05844605 2023-05-06
PREHABILITA
Institut Guttmann
Phase 1 Unknown
NCT04414020 2020-06-04
Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors
Minia University
Phase 1 Unknown
NCT04178057 2019-11-27
Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
Genor Biopharma Co., Ltd.
Phase 1 Unknown
NCT03638765 2018-08-20
Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer
Northwest Biotherapeutics
Phase 1 Unknown
NCT02149459 2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1 Unknown
NCT02672995 2017-08-18
Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial
National Taiwan University Hospital
Phase 1 Unknown
NCT02740933 2016-04-15
Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors
Massachusetts General Hospital
Phase 1 Unknown
NCT00083096 2015-02-10
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Unknown
NCT00516607 2015-02-10
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Unknown
NCT00003842 2013-12-18
IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00002647 2013-09-20
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00004129 2013-09-17
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01012154 2009-11-11
In Vivo Confocal Microscopy Tumor Atlas Study
Carl Zeiss Surgical GmbH
Phase 1 Unknown
NCT00591058 2009-07-17
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
TransMolecular
Phase 1 Unknown
NCT00040560 2005-06-24
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
Copharos
Phase 1 Unknown